Data from the GEPIA2 (gene expression profiling interactive analysis) server show that PHLDA1 is significantly upregulated in several malignancies, including pancreatic cancer, lower‐grade glioma, and melanoma,[32] and it is significantly associated with poor prognosis in pancreatic cancer. This evidence concerns the gene PHLDA1 and central nervous system cancer.